Evaxion Biotech AS (EVAX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
30,131,800
EV to revenue ratio (TTM)
3.03
EV to ebitda
-0.593
Financial Performance
Revenue (TTM)
7,491,000
Gross profit (TTM)
7,491,000
EBITDA
-8,326,000
Profitability
Operating margin (TTM)
-116.00%
Profit margin
-115.50%
Return on assets (TTM)
-26.00%
Return on equity (TTM)
-109.90%
Per Share Metrics
Revenue per share (TTM)
0.94
EPS
-0.5
Diluted EPS (TTM)
-0.5
Book value
1.14
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
3.571
PEG ratio
Price to sales ratio (TTM)
4.022
Price to book ratio (TTM)
3.105
Growth
Quarterly earnings growth (YoY)
-100.00%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
Buy
Hold
Sell
Strong sell
Risk & Volatility
Beta
0.268